![](/img/cover-not-exists.png)
Achievement of early deep remission is associated with lower rates of weekly dosing for adalimumab-treated patients with crohn's disease: data from extend
Sandborn, W. J., Colombel, J. F., Lomax, K. G., Pollack, P. F., Thakkar, R., Camez, A., Chen, N., Yang, M., Chao, J., Mulani, P. M.Volume:
60
Language:
english
Journal:
Gut
DOI:
10.1136/gut.2011.239301.290
Date:
April, 2011
File:
PDF, 84 KB
english, 2011